• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Pilot Plan of the UDI System in Hainan Launched

Pilot Plan of the UDI System in Hainan Launched

Thursday, 03 December 2020 / Published in Medical Device, NMPA Registration in China

Pilot Plan of the UDI System in Hainan Launched

Following the launch of the China’s national UDI system, the Hainan Medical Products Administration (MPA) announced (No.114-2020) the commencement of their pilot plan for the UDI system in Hainan on November 27, 2020.

China’s National UDI System

From January 1, 2021 onwards, all companies with medical devices listed in the first batch are officially required to submit the product identification (DI) in the registration management system for:

  • First registrations
  • Renewal registrations
  • Product change applications

The UDI code must be labelled for products manufactured on or from January 1, 2021 onwards. Watch NMPA’s short introductory video about their online UDI database.

Hainan’s UDI System (Pilot Plan)

In addition to the first batch of medical devices required by China’s national UDI system, Hainan’s UDI system plans to cover 18 types of high-risk class III medical devices (announced in No.9 – 2020 by the China National Health Commission last year on January 14), and 11 specified types of class II and III medical devices (announced in No.114-2020 by the Hainan MPA).

The Hainan MPA addressed the following targets to be achieved:

November – December 2020

  • Establish a working group
  • Make suggestions and preparation for the layout work of the UDI system
  • Organize training and practice
  • The Hainan MPA should keep the NMPA updated on the implementation progress of the pilot plan
  • Applicants in Hainan whose products are mentioned on the specified list of class III medical devices shall submit the DI by the end of December 2020

April 2021

  • Hold an internal meeting to follow up on the implementation progress and review the common issues

December 2021

  • Applicants in Hainan whose products are mentioned on the specified list of class II medical devices shall submit the DI by the end of December 2021
  • The implementation of the UDI system in Hainan shall be completed by the end of December 2021 for sharing information about the registration approvals, clinical data, medicare settlement, etc. online

The following participants are expected to be involved in the pilot plan:

  • The Hainan MPA
  • The Hainan National Health Commission (NHC)
  • The National Healthcare Security Administration of Hainan
  • Hainan class II and III applicants
  • Specified business enterprises and public medical institutes above the B grade
  • The Pharmaceutical Profession Association
  • UDI code agencies

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: hainan, UDI

What you can read next

raw material change passive medical device
NMPA Provides Evaluation Guidance on Material Changes for Passive Medical Devices
2020 Directory of Health Claims Approved for Health Food Expanded
laser therapy devices
Clinical evaluation of laser therapy devices – New guidelines issued

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China health food regulatory updates

    China health food regulatory updates in August 2023

    China health food regulatory updates were annou...
  • Children cosmetics technical guidelines in China

    Children cosmetics technical guidelines in China – Newly issued by NIFDC

    Children cosmetics technical guidelines in Chin...
  • pH Determination Method

    China’s cosmetic safety technical specifications – 21 revision items issued

    China’s cosmetic safety technical specifi...
  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP